Easywell Biomedicals Stock Fundamentals
| 1799 Stock | TWD 67.80 1.20 1.80% |
Easywell Biomedicals fundamentals help investors to digest information that contributes to Easywell Biomedicals' financial success or failures. It also enables traders to predict the movement of Easywell Stock. The fundamental analysis module provides a way to measure Easywell Biomedicals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Easywell Biomedicals stock.
Easywell |
Easywell Biomedicals Company Total Debt Analysis
Easywell Biomedicals' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Easywell Biomedicals Total Debt | 344.06 M |
Most of Easywell Biomedicals' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Easywell Biomedicals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Easywell Biomedicals has a Total Debt of 344.06 M. This is 87.49% lower than that of the Healthcare sector and 80.31% lower than that of the Medical Devices industry. The total debt for all Taiwan stocks is 93.53% higher than that of the company.
Easywell Biomedicals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Easywell Biomedicals's current stock value. Our valuation model uses many indicators to compare Easywell Biomedicals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Easywell Biomedicals competition to find correlations between indicators driving Easywell Biomedicals's intrinsic value. More Info.Easywell Biomedicals is number one stock in ebitda category among its peers. It also is number one stock in net income category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Easywell Biomedicals' earnings, one of the primary drivers of an investment's value.Easywell Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Easywell Biomedicals' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Easywell Biomedicals could also be used in its relative valuation, which is a method of valuing Easywell Biomedicals by comparing valuation metrics of similar companies.Easywell Biomedicals is currently under evaluation in total debt category among its peers.
Easywell Fundamentals
| EBITDA | (140.2 M) | |||
| Net Income | (183.52 M) | |||
| Cash And Equivalents | 399.51 M | |||
| Cash Per Share | 3.49 X | |||
| Total Debt | 344.06 M | |||
| Debt To Equity | 0.41 % | |||
| Current Ratio | 6.64 X | |||
| Book Value Per Share | 7.01 X | |||
| Cash Flow From Operations | (102.55 M) | |||
| Earnings Per Share | (1.31) X | |||
| Number Of Employees | 11 | |||
| Beta | 0.93 | |||
| Market Capitalization | 1.2 B | |||
| Z Score | 1.8 | |||
| Last Dividend Paid | 1.79 |
About Easywell Biomedicals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Easywell Biomedicals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Easywell Biomedicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Easywell Biomedicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Easywell Biomedicals, Inc., a biopharmaceutical and medical device company, develops and commercializes medical devices, drug substances, and pharmaceutical dosage forms in Taiwan and internationally. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan. EASYWELL BIOMEDICAL operates under Medical Devices classification in Taiwan and is traded on Taiwan OTC Exchange.
Pair Trading with Easywell Biomedicals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Easywell Biomedicals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Easywell Biomedicals will appreciate offsetting losses from the drop in the long position's value.Moving against Easywell Stock
| 0.87 | 1432 | Trk Corp | PairCorr |
| 0.85 | 3545 | FocalTech Systems | PairCorr |
| 0.84 | 2603 | Evergreen Marine Corp | PairCorr |
| 0.81 | 2609 | Yang Ming Marine | PairCorr |
| 0.77 | 0050 | YuantaP shares Taiwan | PairCorr |
The ability to find closely correlated positions to Easywell Biomedicals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Easywell Biomedicals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Easywell Biomedicals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Easywell Biomedicals to buy it.
The correlation of Easywell Biomedicals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Easywell Biomedicals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Easywell Biomedicals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Easywell Biomedicals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Easywell Stock Analysis
When running Easywell Biomedicals' price analysis, check to measure Easywell Biomedicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easywell Biomedicals is operating at the current time. Most of Easywell Biomedicals' value examination focuses on studying past and present price action to predict the probability of Easywell Biomedicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easywell Biomedicals' price. Additionally, you may evaluate how the addition of Easywell Biomedicals to your portfolios can decrease your overall portfolio volatility.